Markets:

Overview

News

Currencies

International

Treasuries

Lantern Pharma Inc. - Common Stock (NQ:LTRN)

2.690 -0.100 (-3.58%)

Streaming Delayed Price Updated: 3:21 PM EDT, Jul 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantern Pharma Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)

November 30, 2023

From Lantern Pharma Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 09, 2023

Via Benzinga

Lantern Pharma: Q3 Earnings Insights ↗

November 08, 2023

Via Benzinga

Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights

November 08, 2023

From Lantern Pharma Inc.

Via Business Wire

A Preview Of Lantern Pharma's Earnings ↗

November 07, 2023

Via Benzinga

Lantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ET

November 01, 2023

From Lantern Pharma Inc.

Via Business Wire

The 7 Most Undervalued AI Penny Stocks to Buy: October 2023 ↗

October 24, 2023

Unlock exponential growth with the next big undervalued AI penny stocks to buy, offering tremendous upside ahead.

Via InvestorPlace

Topics Artificial Intelligence

Lantern Pharma to Present at the ThinkEquity Conference on October 19 at 1:30 p.m. ET

October 10, 2023

From Lantern Pharma Inc.

Via Business Wire

Lantern Pharma Announces Publication in Clinical Cancer Research Highlighting the Enhanced Efficacy of LP-184 in Glioblastoma

October 03, 2023

From Lantern Pharma

Via Business Wire

Lantern Pharma Announces First Patient Dosed in the Phase 1 Study for LP-184 in Advanced Solid Tumors

September 25, 2023

From Lantern Pharma Inc.

Via Business Wire

Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas

September 18, 2023

From Lantern Pharma Inc.

Via Business Wire

The 3 Most Undervalued Machine Learning Stocks to Buy in September 2023 ↗

September 14, 2023

Here are three machine-learning stocks that may be ready to move much higher when investor sentiment changes.

Via InvestorPlace

Lantern Pharma to Present Data Highlighting the Anti-Tumor Potency of Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas at the Society of Hematologic Oncology Annual Meeting

August 31, 2023

From Lantern Pharma Inc.

Via Business Wire

3 AI Stocks That Still Trade Under $10 Per Share ↗

August 28, 2023

With the artificial intelligence (AI) boom ramping up, check out this short list of hot AI stocks under $10.

Via InvestorPlace

Topics Artificial Intelligence

Lantern Pharma Expands AI Capabilities of RADR® Platform to Accelerate the Clinical Development of Immune Checkpoint Inhibitors

August 28, 2023

From Lantern Pharma Inc.

Via Business Wire

The 3 Most Undervalued Machine Learning Stocks to Buy Now: August 2023 ↗

August 23, 2023

Machine learning stocks still have a lot of room left to rise despite a short-term pullback in their stock prices.

Via InvestorPlace

8 Best Artificial Intelligence Stocks Under $10

August 18, 2023

If you want to get in on artificial intelligence (AI) but don’t want to spend a lot, why not consider artificial intelligence stocks under $10? Learn more.

Via MarketBeat

Topics Artificial Intelligence Economy

The 3 Most Undervalued AI Penny Stocks to Buy Now: August 2023 ↗

August 16, 2023

Not only would I take full advantage of the pullbacks in heavyweight AI stocks, I’d also take advantage of the drops in top AI penny stocks.

Via InvestorPlace

Topics Artificial Intelligence

Lantern Pharma Receives Notice of US Patent Allowance for Drug Candidate LP-184 for the Treatment of Rare Pediatric Brain Cancer, ATRT

August 14, 2023

From Lantern Pharma Inc.

Via Business Wire

Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights

August 09, 2023

From Lantern Pharma Inc.

Via Business Wire

3 AI Penny Stocks With the Potential to Make Your Financial Dreams Come True ↗

August 09, 2023

These top three AI penny stocks offer immense upside ahead, potentially becoming future market leaders amid a $15.7 trillion projection.

Via InvestorPlace

3 AI Stocks You’ll Regret Not Buying Soon ↗

August 08, 2023

AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.

Via InvestorPlace

7 AI Stocks to Buy Under $5 in August 2023 ↗

August 02, 2023

These AI stocks to buy for under $5 in August have strong potential as the sector grows throughout 2023 and beyond.

Via InvestorPlace

RedChip Launches 'Small Stocks, Big Money' Podcast

August 02, 2023

Via ACCESSWIRE

Lantern Pharma to Report Second Quarter 2023 Operating & Financial Results on August 9, 2023 at 4:30 p.m. ET

August 02, 2023

From Lantern Pharma Inc.

Via Business Wire

3 AI Stocks to Buy Under $10 in August 2023 ↗

August 01, 2023

The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10.

Via InvestorPlace

7 AI Penny Stocks that Could Hit $5 Soon ↗

July 30, 2023

Here are seven AI penny stocks with huge potential as you look to make life-changing money from the advance of artificial intelligence.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 18, 2023

Via Benzinga

Lantern Pharma to Participate and Present at Multiple Upcoming Conferences

July 17, 2023

From Lantern Pharma Inc.

Via Business Wire

Oncotarget Publishes New Data by Lantern Pharma, an AI Company Developing Cancer Therapies, Further Supporting Clinical Advancement of LP-284, a Novel Synthetically Lethal Drug Candidate for Non-Hodgkin’s Lymphomas

June 26, 2023

From Lantern Pharma Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.